Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005426-23Phase 2Terminated
Phase 2 trial of adalimumab in adhesive capsulitis (AC) (2 arms), sponsored by Pierre Schydlowsky. Primary endpoints: 50% improvement in passive motion and Safety. Started Nov 2006; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005426-23.